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Recent  evidence on the  effect of subcutaneous  vaccination  with  influenza 
virus showed that the incidence of epidemic influenza was consistently reduced 
by about 75 per cent when the period between vaccination and epidemic was 
short (1).  The present communication presents briefly a  study on a  similar 
vaccine in  which  the period between vaccination and epidemic was about  1 
year.  Since there is reason to think that the vaccines used in the two studies 
were in many ways comparable, the present results may be considered as an 
extension of the previous observations. 
Methods 
Preparation of the  Vaccine.--Strains employed: The PR8 strain of influenza A  and the 
Lee strain of influenza B were used for the production of most of the vaccine.  In one small 
experiment (done in institution 7) the vaccine used was made with the PR8 and W.S. strains 
of influenza A  only. 
Concentration of virus: The virus was grown in the allantoic sac of the developing chick 
embryo and was concentrated from ailantoic fluid by adsorption on the precipitate which 
forms when frozen allantoic fluid is thawed.  The details of the technique have been previously 
described (2).  After concentration, if sterility tests were negative, formalin was added to a 
final concentration of 0.1 per cent.  Concentrates of PR8  and Lee were combined in equal 
proportions and the mixture was frozen and dried (3).  Infectivity tests (in mice and chick 
embryos) following drying were uniformly negative for active virus.  Seven different lots of 
such vaccine were prepared and each lot was tested in human beings before use in the field 
to insure that its antigenic potency was of the right order.  The vaccine was stored in the 
dried state for an average of 2 to 3 months before use3 
t By this method over 90 per cent of the PR8 and 75 to 85 per cent of the Lee virus was 
removed  from the allantoic fluid.  The main disadvantage of this technique is the large amount 
of insoluble precipitate left in the vaccine.  The adsorption-elution phenomenon of influenza 
virus with avian red blood cells (4) provided an obvious method of virus concentration which 
would eliminate much non-virus material and which we immediately attempted to use.  While 
the concentration of influenza B virus was satisfactory by this technique the results with PR8 
were disappointing.  At 37°C. for 2 hours it was not possible to elute more than S0 per cent 
of the adsorbed PR8 virus (see (4) fig. 3) and the prolonged incubation at this temperature 
greatly favored the multiplication of bacterial contaminants.  For these reasons the method 
was not used.  Francis and Salk subsequently published a similar method (5) for the use of 
the adsorption-elution principle but made no mention of experiencing these difficulties. 
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Institutions  Used for  Vaccination.--Penal  institutions  in  five widely separated  states  of 
midwestem, southern, and eastern United States were chosen for study.  These institutions 
offered obvious advantages for this type of work since in each of the groups the medical care 
was  good,  there  was  adequate,  readily  available hospital  space,  and  there  were full-time 
physicians in attendance.  Seven such institutions were studied and in the description below 
they will be referred to by number.  The vaccinations were done on volunteers only, and 
usually because the number of volunteers was less than half the total population, they were 
aU vaccinated and the remainder of the population was listed as controls.  The list of vaccinated 
and controls was made up at the time of inoculation and special groups such as those in isolation 
quarters,  hospital  attendants,  and  detached  workers were excluded.  Mter  completion of 
the vaccination no new men were admitted to either group. 
Administration  of  Vaccine.--The  vaccine was  rehydrated  in  distilled water  just  before 
administration and aliquot portions of the seven vaccine lots were mixed in the fluid state so 
that  each individual in  the  seven institutions  received equivalent material.  The  vaccine 
was injected subcutaneously in a volume of 1 cc.  This inoculum contained the concentrate 
from 5 cc. of PR8 and 5 cc. of Lee allantoic fluid.  At institution 7 the inoculum contained 
the concentrate of 5 cc. of PR8 and 5 cc. of W.S. aUantoic fluid.  Special attention was de- 
voted to insuring equal amounts of insoluble precipitate in each dose. 
Reactions to Vaccination.--The  injection of this material was not followed by any untoward 
immediate reactions.  Between 12 and 24 hours after inoculation there were a few individuals 
(approximately 1 in 200 ) who developed a mild febrile response (100.0 to 100.5°F. by mouth) 
and some had slight chills and malaise but these reactions were of brief duration and were not 
serious.  Slight redness and swelling at the site of injection with moderate sore arm for 24 
hours was common. 
RESULTS 
Serological  Response  Following  Vaccination.--A  number  of  individuals  at 
each institution  were bled before vaccination  and again 2  weeks, and 11 to 14 
months,  after vaccination.  A  few  additional  subjects  had  only  two  blood 
specimens  taken,  the  second  being  either  at  the  2  week  or  11  to  14  month 
interval.  These  sera  were  tested  for  agglutination  inhibition  titer  against 
influenza  A  strains  PR8  and  NY-43 ~ and  for  complement-fixing  antibodies 
against NY-43  (6,  7).  In every case all the sera from one individual were run 
in the same test and all runs  were corrected to the same level through  the use 
of standard  ferret sera.  Table I  gives in summary  form the geometric mean 
antibody levels at these various time intervals. 
The  mean  antibody  increase  2  weeks after  vaccination  was  approximately 
sixfold  against  the  strains  used  in  vaccination  (Lee  and  PR8)  and  fourfold 
against  the current  strain  NY-43,  whether  tested  by agglutination  inhibition 
or complement fixation.  This is the same order of rise as was described previ- 
ously when amounts  of virus of this order of size were given to human  beings 
(8,  2).  Although  the mean level dropped over a  year long interval, neverthe- 
less the  titers of PR8 and Lee antibodies  were still about  three times the pre- 
2NY-43 is an influenza A strain isolated from a patient at the height of the 1943-44  epi- 
demic in New York City.  It was isolated by inoculation of throat washing filtrate into the 
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vaccination  level,  while  the  NY-43  titers  were  twice  the  original  by  both 
methods of testing. 
While the  11  to 14 month specimens were taken during an  epidemic of in- 
fluenza A it seems unlikely that infection unduly raised the mean titer of the 
tested group since: (a) Individuals giving a history of infection were excluded. 
(b)  The over-all attack rate of influenza was low among the populations con- 
cerned  (5 per cent),  and the number of unapparent infections was probably 
correspondingly small.  (c) Individuals showed a great uniformity of response 
with a  1 year level consistently below their 2 week level.  (d)  The results with 
influenza B, in the absence of a  B  epidemic, corresponded well to those with 
TABLE  I 
Change in Antibody Levels Following Vaccination of Human Subjects wltk PR8 and 
Lee Virus 
Testing strains 
PR8 
agglutination 
Lee 
agglutination 
NY-43 
agglutination 
NY-43 
complement fixa- 
tion 
No. of subjects 
prevac- 
cination 
197 
121 
44 
14 
Mean serum antibody 
titers 
2 wks.  11-14 mos. 
postvac-  postvac- 
cinxtion  cination 
1209  704 
709  340 
163  96 
58  30 
61 
No.  times mean increase 
in titer over previous  level  Per cent of individ- 
uals 30 per cent  or 
.  more above pre- 
vaccination titer 
2  wk  11- 4  n os.  at 11-14 mos. 
L6 
].8 
6.1 
5.9 
3.7 
4.1 
64 
L2 
84 
90 
76 
58 
61  61-64 
influenza A.  (e) Eighty-five and 90 per cent of vaccinated persons (in respect 
to PR8 and Lee antibody titer) were, after 1 year, significantly (30 per cent) 
above their prevaccination level.  In view of these  facts it is  felt that  the 
elevated titer after 1 year was a result of vaccination. 
Collection of Clinical Data.--The vaccinations were done in the last 2 months 
of 1942 and early in 1943 and no influenza epidemic was reported in any of the 
groups until the nation-wide epidemic started in November, 1943, when institu- 
tional epidemics lasting 4  to 6 weeks were reported in all seven groups, con- 
current with influenza in the general population. 
At each institution  the diagnosis  of influenza  was made by the attending 
physicians.  All cases included in the study were admitted to the institution 
hospitals  for  observation.  The  disease  was  very similar  clinically  to  cases 
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not high nor was it usually elevated for more than 2 days.  Coryza and cough 
were common but less than half had typically severe constitutional symptoms. 
Few individuals were seriously ill, convalescence was short, and there were few 
complications and no deaths.  Because of the relatively mild symptoms the 
differential diagnosis from other respiratory diseases was not always easy, and 
in selecting the group considered to have influenza error was made in the direc- 
tion of including rather than excluding suspicious cases.  This would, of course, 
tend to decrease any specific effect of vaccination.  As in previous studies the 
main criteria for diagnosis were fever (100.0°F. or more by mouth) and respira- 
tory symptoms.  Those making the diagnosis were, with one possible excep- 
tion, unaware of the patient's status in the study. 
Etiology of Epidemics.--In four institutions (1, 2, 3, and 7) paired acute and 
convalescent sera were obtained from a  few patients with influenza and the 
number of these showing a  fourfold or greater rise  to the  PR8 and NY-43 
strains was sufficient to indicate that the epidemic was in all probability due to 
influenza A.  Two influenza A strains were isolated from patients in institutions 
2 and 3, on primary inoculation of throat washings into the amniotic sac of 
chick embryos.  In four institutions (3, 4, 5, and 6) a number of convalescents 
were bled 1 to 2 months following the disease.  These convalescent sera were 
tested against the PR8 strain and part of them against the Lee strain.  At the 
bottom of Table II is shown the distribution of PR8 titers in these groups 
together with a group of normal pre-epidemic titers from the same institutions. 
Among the convalescent sera only 10 per cent had a titer of 512 or less, while 
89 per cent of the normal group fell below this level.  The mean titers were 
also considerably elevated above that of the general population in respect to 
influenza A but not influenza B.  This is reasonably clear evidence not only 
that the epidemics in these institutions were influenza A but also that the great 
majority of cases selected for testing had been infected. 
Evaluation of Clinical ResuIts.--For purposes of analysis the population of 
each institution was divided into three groups: (a) Those who were vaccinated, 
(b) those listed as controls at the time of vaccination and who were still resident 
at the time of the epidemic, and (c) inmates admitted since vaccinations were 
performed (called recent group).  The first two groups were greatly reduced 
from their original size due to discharges during the 1 year interval.  All three 
groups excluded special prisoners as mentioned above. 
In Table III are given the data regarding the number of cases of influenza 
observed in the different groups, together with calculated attack rates and the 
percentage reduction of attack rate in the vaccinated group compared with the 
controls.  Owing to the loss of subjects and the low general attack rate the 
number of cases for consideration in any institution is small.  Nevertheless the 
attack rate in the vaccinated was consistently lower than that of the control 
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the results of individual institutions varied from this average figure by a statis- 
tically significant amount, so that the differences in reduction from 23 to 58 
per cent could be due entirely to sampling.  Although  the result in many of 
the groups is not significant statistically,  the total result, since all the groups 
TABLE II 
Summary of  Serological Tests Done in Different Institutions to Establish t~ Etiology of  Epidemics 
Analysis of Paired Sera 
Institution No.  No. of paired serz  NO. of pairs positive*  No. of pairs negative for 
examined  for influenza A  influenza A 
1  15  12  3 
2  6  4  2 
3  2  2  0 
7  4  3  1 
Analysis of Convalescent Serum Tiler against Influenza A~ 
Individuals in titer group  Geometric mean titer 
Institution No. 
Control popu- 
lation... 
No. of 
conval. 
sera 
i 
~I  ~' 
per  per,  per 
e¢,nt  cent  ~ cent 
11  0  i 12 
0  01  6 
0  31  8 
0  31  3 
17 
30 
36 
30 
85 
Less 
than 64 
per cenI 
20  33  29 
~  ~  More 
~  than 
7~  ~  ~  4096  g  o  g 
per  per  per 
¢enl  cent  cent  per ce~ 
18  35  12  12 
37  37  10  10 
39  22  14  14 
17  28  46  3 
11  I  0  0 
Influenza  Influenza 
A  B 
1002  -- 
2520  158 
1270  158 
1620  130 
205  187 
* The criteria for a positive result were that there be at least a fourfold rise in titer in two 
of the following three serological tests: Agglutination inhibition titer with PR8 and NY-43, 
and complement fixation titer with NY-43. 
Sera from individuals  included as cases in the study, taken 4 to 8 weeks after the acute 
illness. 
are consistent, is highly significant.  It should also be noted that the recent 
inmates had attack rates very similar to those of the control groups. 
Because the vaccinated subjects in these institutions were a  group of volun- 
teers and not chosen at random, it was desirable to eliminate as far as possible 
any linked variables which might have influenced the result in either direction. 
From three of the institutions (1, 2, and 3) data were obtained concerning the 
age, length of residence, location of cell block, occupation during the day, and Institution  Total 
No.  popula-  tion 
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color of the  total population.  The attack rates of unvaccinated controls in 
these various categories were determined and from them were calculated the 
number  of cases expected among  the vaccinated in each  category, assuming 
that the vaccine had no effect.  The same order of differences was found be- 
tween the calculated expected rate and the actual rate as was found between 
the crude rates in the entire group.  In other words, the distribution of vac- 
cinated and control groups among these categories had no significant effecton 
the crude rates given in Table III. 
One possible linked variable could not be ruled out by these calculations, 
namely,  that some  unknown  factor having  an  effect on  incidence might be 
TABLE III 
Summary of Clinical  Data on the Invidence  of Influenza  among  Control and  Vaccinated 
Populations and among Those Recently Admitted to the Seven Institutions under Study 
Total 
cases 
Fotal  ..... 10,832 
No. in 
Recent  Con-  Vacci- 
trol  '  hated 
group  group'  group 
1796  337  852]  607 
1356'301  647  408 
15611704  512  345 
10471  415  353  279 
1298  t  396  458  444 
i 
3116  i  949  1480  687 
658,  334  149  175 
3436  4451 2945 
122 
107 
87 
40 
52 
107 
56 
571  t 
No. of cases of 
influenza  in 
[ 
!Recent Con- Nacci- 
trol ,nated 
group  group t  group 
29  63  30 
30  53  24 
48  29  10 
18  15  7 
171  20  15 
40  I  56  11 
38  I  10  8 
220  246  105 
Attack rate in 
270 
Con-  Vacci- 
Recent  trol 'nated 
group  group !  group 
8.6  7.4  14.9 
10.0  8.215.9 
6.8  5.7  2.9 
4.3  4.2  2.5 
4.3  4.4  3.4 
4.2  3.8  1.6 
11.4  6.7  4.6 
( 
6.4  5.5  3.6  [ 
Reduction 
between 
control 
and vac- 
clnated 
groups 
~$r  Cen~ 
34 
28 
49 
40 
23 
58 
31 
35 
linked with the fact of volunteering?  Three considerations make the opera- 
tion of such a factor in the present study unlikely: (a) The means of making a 
diagnosis always included an objective factor, namely fever.  (b) The lapse of 
a  year's time between inoculation and infection decreased the degree of con- 
sciousness of the subjects regarding their part in an experiment, in fact many 
saw no connection.  (c) The group of recent admissions formed a sort of added 
control group which had not been separated into volunteers and controls and 
yet had nearly the same attack rate (a little higher) as the regular controls. 
3  Such a factor was demonstrated in a common cold study  by Diehl and coworkers (9) in which 
they obtained a reduction of attack rate following the injection of saline in volunteers.  Their 
experiment was very different from the present one however, in that (a) the subjects chosen 
were all highly susceptible to colds, (b) they were treated every 2 weeks, and (c) the comparison 
oi attack rates was made between the years of treatment and, the year prior to  treatment 
(by history).  These differences may have enhanced  the apparent curative effects of "treat- 
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DISCUSSION 
A number of vaccination experiments were carried out during the  1940-41 
epidemic of influenza A in this country using a ground chick embryo vaccine 
described by Horsfall and  collaborators  (10).  Martin  and  Eaton  (11)  and 
Brown, Eaton, et al. (12) were the only groups that reported experiments with 
this preparation in which a significant reduction in attack rate followed vac- 
cination.  They reported attack rate reductions of 32 and 52 per cent in two 
institutions and of roughly 50 and 60 per cent in two other hospital groups 
that were less well controlled.  It seems significant that all these results were 
obtained in epidemics which occurred at the time or shortly after vaccination 
was performed.  Following this, Dalldorf et al.  (13) and Siegel et al.  (14) in 
two  independent  experiments  with  the  same  type  of vaccine  obtained  no 
evidence of reduction of the attack rate, with an interval between vaccination 
and epidemic of 6 and 8 weeks.  Horsfall et al.  (15) reported a  much larger 
series with  the same preparation, in which the vaccination-epidemic interval 
was 4 months.  They obtained an attack rate reduction of 25 per cent on a 
clinical basis.  This would seem to be a significant reduction were it not for 
the fact that the results in individual institutions showed such enormous vari- 
ation, well  beyond  the sampling error.  This  large variation  precludes any 
definite conclusions being drawn from these results. 
Following the  1940-41  experience an investigation was  carried on in  this 
laboratory (8) in which some of the factors affecting the human antibody re- 
sponse to parenteral vaccination were evaluated.  Among other things it was 
shown that 1 cc. of a  20 per cent chick embryo vaccine or 0.5 cc. of infected 
allantoic fluid raised the mean antibody level of a population about twofold 
while the inoculation of the virus from 5 cc, of allantoic fluid raised the mean 
level sixfold.  The same enhanced antibody response was obtained with large 
amounts of virus concentrated by two different methods (8, 2) and this observa- 
tion was confirmed by Hare et al. (16). 
During  the  epidemic of  1943--44 the  members  of the  Commission on In- 
fluenza (1) tested a vaccine which consisted of virus concentrated from allantoic 
fluid by adsorption on and elution from embryonic red cells (4, 5).  While no 
human antigenic  studies  using  virus prepared in this way have as yet been 
published, there is no reason to expect that  the human response would differ 
in any important way from that obtained with similar amounts of virus con- 
centrated by other methods.  Using this vaccine the reduction in incidence of 
epidemic influenza  was  uniformly good (75 per  cent)  for cases whose  onset 
was within 6 weeks of the time of vaccination (1).  The enhanced protective 
effect of this vaccine over that used in 1940-41 might have been anticipated in 
view of the better antibody response produced by concentrated preparations. 
Most of the evidence in the report of members of the Commission on In- 
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total of all reported cases is considered in terms of the length of time between 
vaccination and onset, it is found that the effect of vaccination was greatest in 
the 2nd week following inoculation (approximately 85 per cent reduction) and 
was poorest in  the  6th  and  7th weeks when the reduction (in 94 cases) due 
to vaccination fell to about 40 per cent.  The results of Eaton and Meiklejohn 
stand out in the report as an exception since they obtained only a 30 per cent 
reduction in the vaccinated group.  The low order of vaccine effect obtained 
by these workers is significantly different from the results of all the other in- 
vestigators and it may be pertinent that their observations covered only cases 
in which there was a period of 6 to 12 weeks between vaccination and infection 
while all the results showing a high order of vaccine effect were in cases occur- 
ring in the first 6 weeks after inoculation. 
The present report covers a group of individuals vaccinated 11 to 14 months 
before the  epidemic with  material as high in virus  content and at  least as 
antigenically potent as that used by the group mentioned above.  Serological 
evidence indicates that vaccinated individuals had of the order of three times 
as much circulating antibody at the time of the epidemic as they had before 
vaccination.  Those  individuals  vaccinated  in  seven  different institutions 
showed a  consistently lower attack rate  than did  the corresponding unvac- 
cinated controls.  The reduction in attack rate (35 per cent) was not signifi- 
cantly different from the effect obtained  by Eaton and Meiklejohn 6  to  12 
weeks after vaccination with a preparation of similar potency. 
This evidence indicates that both in 1940-41 and in 1943-44 a definite reduc- 
tion in influenza attack rate was obtained with formalin-killed vaccine, when 
given in the face of or shortly before the outbreak.  In both instances there 
was evidence that the peak of the immune effect declined rapidly, so that with 
the weak preparation used in 1940-41 no clear cut immunity was evident at 6 
and 8 weeks, while with the more potent, concentrated preparations the maxi- 
mum effect in the 2nd week declined markedly by the 6th and 7th weeks but 
then persisted at a low level for a year.  Such a precipitous drop in immunity 
from a high peak with ultimate levelling off and with a lesser order of decline 
at a low level is a well established immunologic phenomenon. 
If this view of the facts is relevant, it would obviously mean that there would 
be much greater economy in the administration of vaccines of this type if they 
were given in the face of an outbreak, after its identification, rather than if 
the vaccine were administered in advance of each epidemic season, since the 
exact seasonal onset and yearly periodicity of influenza epidemics is too capri- 
cious to permit accurate prediction.  The protection obtained after 2 months' 
lapse of time is insufficient for practical purposes, and furthermore the results 
of  Hale  at  the  University of  Iowa  (1) and  results  from the  laboratory at 
the  City College  of  New York  (1) have  shown  that  immunity may be  ex- 
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SUM-MARY 
The  administration  to  human  beings  of forma]~n-killed  influenza  virus, 
concentrated from allantoic fluid, resulted in a high order of antibody response 
within 2 weeks after injection.  Even after 1 year the great majority of in- 
dividuals vaccinated had antibody levels considerably above their prevaccina- 
fion fiter for the PR8, Lee, and a current 1943 strain.  An investigation of the 
occurrence of epidemic influenza A in seven widely separated  populations,  1 
year after vaccination of part of these groups, showed that  the attack  rate 
among  vaccinated persons  was  consistently lower  than  that  of control in- 
dividuals.  The average reduction in attack rate was of the order of 35 per 
cent. 
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